AbbVie Inc (NYSE: ABBV) is having an overwhelmingly rough start to the trading session this morning, and for good reason. Legendary short-side reporters at Citron have picked the company as a target. Of course, the news led to fear among investors, sending the stock screaming for the bottom. Today, we’ll talk about: The tweet from … Read more
AbbVie Inc (NYSE: ABBV) isn’t having the best of starts to the trading session this morning, and for good reason. The company announced clinical data that missed expectations. Of course, investors are upset about the news, sending the stock into the red. Today, we’ll talk about: The data; what we’re seeing from ABBV as a … Read more
AbbVie Inc (NYSE: ABBV) is having an overwhelmingly strong start to the trading session in the pre-market hours this morning and for good reason. The company announced the preliminary results of its modified Dutch auction tender offer. Of course, the results proved to be positive, leading to excitement among investors and sending the stock screaming … Read more
AbbVie Inc (NYSE: ABBV) is having a relatively strong start to the trading session this morning after announcing that it has submitted a marketing authorization application to the European Medicines Agency. The company also announced a “Dutch auction” tender offer that will allow the company to purchase shares from current shareholders. Of course, the news … Read more
AbbVie Common Stock (NYSE: ABBV) is having an overwhelmingly strong day in the market today, and for good reason. The company reported earnings ahead of expectations. Of course, this led to excitement among investors, pushing the stock upward and prompting our partners at Trade Ideas to send the alert. Currently (9:55), ABBV is trading at … Read more
TG Therapeutics Inc (NASDAQ: TGTX) TG Therapeutics is having an incredibly strong day in the market today. After starting the trading session off well into the green, the stock has only continued with impressive gains since the opening bell rang. Below, we’ll talk about what we’re seeing from TGTX, why, and what we’ll be watching … Read more
AbbVie Common Stock (NYSE: ABBV) | Coherus Biosciences Inc (NASDAQ: CHRS) AbbVie and Coherus Biosciences were both off to a relatively normal start in the market today. While both were trading in the green, they weren’t gaining by much. That is, until minutes ago. At the moment, ABBV is spiking and CHRS is falling apart. … Read more
Gilead Sciences, Inc. (NASDAQ: GILD) Gilead Sciences is one of the best companies in biotech. They’ve created an incredible HCV franchise, have worked heavily in the HIV arena and have promising data to share with regard to hepatitis B. However, for some reason on the balance of fear and greed, investors remain fearful. However, if … Read more
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) Achillion Pharmaceuticals is having an incredible day in the market after announcing interim results from a Phase 2 study evaluating odalasvir, an NS5A inhibitor. Today, we’ll take a look at the interim data offered by the company, how the market reacted to the news, and what we can expect to … Read more
Abbott Laboratories (ABT) spun-off biopharmaceutical business AbbVie (ABBV) in 2013. Baxter International (BAX) must have been paying attention. The company spun-off its own biopharmaceutical business this year. The new business is called Baxalta (BXLT). Baxalta has a market cap of $27 billion, while AbbVie has a market cap of $114 billion. Baxter and Abbott both … Read more